1675 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33197121 | Prescription trends and costs of diabetes medications in Australia between 2003 and 2019: an analysis and review of the literature. | 2022 May | 1 |
2 | 33430738 | High Throughput Study for Molecular Mechanism of Metformin Pre-Diabetic Protection via Microarray Approach. | 2022 | 1 |
3 | 34427916 | Metformin accelerates wound healing by Akt phosphorylation of gingival fibroblasts in insulin-resistant prediabetes mice. | 2022 Feb | 1 |
4 | 34713480 | Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. | 2022 Mar | 1 |
5 | 34761355 | Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect? | 2022 Mar | 1 |
6 | 34779103 | Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin. | 2022 Mar | 1 |
7 | 34779127 | Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus. | 2022 Feb | 1 |
8 | 34787028 | Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. | 2022 Jan | 1 |
9 | 34897595 | Impaired metabolic effects of metformin in men with early-onset androgenic alopecia. | 2022 Feb | 1 |
10 | 34907435 | Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial. | 2022 Mar 1 | 2 |
11 | 34919671 | Hypothalamic miR-1983 Targets Insulin Receptor β and the Insulin-mediated miR-1983 Increase Is Blocked by Metformin. | 2022 Jan 1 | 1 |
12 | 34953068 | The use of glucose-lowering medications for the treatment of type 2 diabetes mellitus during pregnancy in the United States. | 2022 Mar | 1 |
13 | 34957859 | Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome. | 2022 Feb 1 | 5 |
14 | 34983210 | [CME/Answers: Metformin - Dos and Don'ts]. | 2022 Jan | 1 |
15 | 34983571 | Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients. | 2022 Jan 4 | 1 |
16 | 35038311 | Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis. | 2022 Feb 7 | 3 |
17 | 35044756 | Synergistic Effects of Combined Anthocyanin and Metformin Treatment for Hyperglycemia In Vitro and In Vivo. | 2022 Feb 2 | 1 |
18 | 35045841 | Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China. | 2022 Jan 19 | 3 |
19 | 35046683 | Glycaemic Control in Youth and Young Adults: Challenges and Solutions. | 2022 | 1 |
20 | 35067907 | An update on mode of action of metformin in modulation of meta-inflammation and inflammaging. | 2022 Apr | 2 |
21 | 35120288 | Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial. | 2022 Feb 1 | 1 |
22 | 35138021 | Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study. | 2022 Jun | 1 |
23 | 35139776 | Metformin attenuates high glucose-induced injury in islet microvascular endothelial cells. | 2022 Feb | 1 |
24 | 35142713 | One Bout of Resistance Training Does Not Enhance Metformin Actions in Prediabetic and Diabetic Individuals. | 2022 Jul 1 | 1 |
25 | 35144596 | Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes. | 2022 Feb 10 | 1 |
26 | 35149444 | Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review. | 2022 Apr | 1 |
27 | 35163187 | Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport. | 2022 Jan 23 | 3 |
28 | 35179472 | [Contraception in the context of PCOS]. | 2022 Feb | 1 |
29 | 35217034 | The interactions of CAP and LYN with the insulin signaling transducer CBL play an important role in polycystic ovary syndrome. | 2022 Jun | 1 |
30 | 35249270 | Benefits of metformin add-on insulin therapy (MAIT) for HbA1c and lipid profile in adolescents with type 1 diabetes mellitus: preliminary report from a double-blinded, placebo-controlled, randomized clinical trial. | 2022 Apr 26 | 5 |
31 | 35252207 | The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular. | 2022 | 1 |
32 | 35269852 | Metformin and Breast Cancer: Where Are We Now? | 2022 Feb 28 | 1 |
33 | 35282660 | Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis. | 2022 Feb | 1 |
34 | 35345424 | Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study. | 2022 | 2 |
35 | 35351535 | Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial. | 2022 Apr | 1 |
36 | 35367225 | Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder. | 2022 Jun | 1 |
37 | 35370738 | Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin. | 2022 | 1 |
38 | 35409282 | Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS. | 2022 Apr 1 | 4 |
39 | 35450869 | Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study. | 2022 Apr | 1 |
40 | 35454163 | Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications. | 2022 Apr 14 | 2 |
41 | 35462933 | PRDM16 Regulating Adipocyte Transformation and Thermogenesis: A Promising Therapeutic Target for Obesity and Diabetes. | 2022 | 1 |
42 | 35497918 | Correlation of Serum IGF-1R, VEGF, and ET Levels with Bone Mineral Density in Type 2 Diabetic Mellitus Patients Treated with Metformin Plus α-Glucosidase Inhibitors. | 2022 | 1 |
43 | 35498407 | Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. | 2022 | 1 |
44 | 35503642 | Unopposed estrogens: current and future perspectives. | 2022 Apr | 2 |
45 | 35525318 | The effect of metformin on glucose metabolism in patients receiving glucocorticoids. | 2022 May 4 | 1 |
46 | 35558742 | Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China. | 2022 | 1 |
47 | 35578807 | Effects of chronic metformin treatment on training adaptations in men and women with hyperglycemia: A prospective study. | 2022 Jun | 1 |
48 | 31234219 | The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia. | 2021 Jan | 2 |
49 | 32157481 | Metformin and heart failure-related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials. | 2021 Nov | 1 |
50 | 32533543 | Metformin, Microbiome and Protection Against Colorectal Cancer. | 2021 May | 1 |